Cost-Utility Analysis of Enzalutamide for Patients with Previously Treated Metastatic Castration-Resistant Prostate Cancer (MCRPC)

May 1, 2014, 00:00
10.1016/j.jval.2014.03.521
https://www.valueinhealthjournal.com/article/S1098-3015(14)00572-5/fulltext
Title : Cost-Utility Analysis of Enzalutamide for Patients with Previously Treated Metastatic Castration-Resistant Prostate Cancer (MCRPC)
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00572-5&doi=10.1016/j.jval.2014.03.521
First page : A89
Section Title : Cancer
Open access? : No
Section Order : 1570
Categories :
Tags :
Regions :
ViH Article Tags :